9 – Case study: successful development and approval of a new medical device

[1]  Aliya Kuzhabekova,et al.  Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences , 2009, Journal of Law, Medicine & Ethics.

[2]  J. Marchal,et al.  How Can Nanotechnology Help to Repair the Body? Advances in Cardiac, Skin, Bone, Cartilage and Nerve Tissue Regeneration , 2013, Materials.

[3]  Jordan Paradise,et al.  Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology , 2009, Journal of Law, Medicine & Ethics.

[4]  Fergal McCaffery,et al.  Software process improvement to assist medical device software development organisations to comply with the amendments to the medical device directive , 2012, IET Softw..

[5]  G. Trevi,et al.  Implantable Cardioverter Defibrillators and Cellular Telephones: Is There Any Interference? , 1999, Pacing and clinical electrophysiology : PACE.

[6]  Kevin Fu,et al.  Controlling for cybersecurity risks of medical device software , 2013, Commun. ACM.

[7]  A. Das,et al.  Lack of publicly available scientific evidence on the safety and effectiveness of implanted medical devices. , 2014, JAMA internal medicine.

[8]  Mehul B. Patel,et al.  Do Media Players Cause Interference with Pacemakers? , 2009, Clinical cardiology.

[9]  Martin Höst,et al.  A case study on software risk analysis and planning in medical device development , 2014, Software Quality Journal.

[10]  Rance Cleaveland,et al.  Formal verification of software-based medical devices considering medical guidelines , 2013, International Journal of Computer Assisted Radiology and Surgery.

[11]  M. Hours,et al.  Interference between Active Implanted Medical Devices and Electromagnetic Field Emitting Devices is Rare but Real: Results of an Incidence Study in a Population of Physicians in France , 2014, Pacing and clinical electrophysiology : PACE.

[12]  Josh Rising,et al.  The Food and Drug Administration's unique device identification system: better postmarket data on the safety and effectiveness of medical devices. , 2014, JAMA internal medicine.

[13]  John H. Linehan,et al.  Medical Device Innovators and the 510(k) Regulatory Pathway: Implications of a Survey-Based Assessment of Industry Experience—Part 2: Medical Device Ecosystem and Policy , 2013 .

[14]  John H. Linehan,et al.  Medical Device Innovators and the 510(k) Regulatory Pathway: Implications of a Survey-Based Assessment of Industry Experience , 2012 .

[15]  Guy Malki,et al.  Medical iPad use in the cardiac catheterization and echo laboratories , 2014, The International Journal of Cardiovascular Imaging.